O. Shchur, Volodymyr Melnykov, Volodymyr Marina, R. Yaremkevych, R. Zhuk, V. Bochar, Vitaliy Petrov, O. Samchuk, Dmytro Romanchak
The article raises a question about the possible and effective kidney transplantation in elderly patients with various severe comorbidities. The analysis is based on an example of successful kidney transplantation from a deceased donor when a 67-year-old patient had severe concomitant background: obesity, diabetes mellitus, and cardiovascular disturbances. Despite unfavorable prognosis and further unpredictable illnesses such as COVID-19, candidal esophagitis, coronary attack, and pneumonia, the patient has not develop graft injury or rejection and kept sufficient kidney function. The research was mainly focused on coexisting illnesses and their influence on kidney transplantation consequences. Following disease groups were discussed regarding their impact on transplantation outcomes and prognosis: arterial hypertension, cardiac disorders, diabetes mellitus, and obesity. Patient’s age, previous interventions, and comorbidities were observed for association with outcomes and risk of graft rejection. A review of available publications compared approaches for recipient selection in different clinical centers as well.
{"title":"KIDNEY TRANSPLANTATION IN AN AGED PATIENT WITH MULTIPLE COMORBIDITIES: A REVIEW BASED ON UNUSUAL CLINICAL CASE","authors":"O. Shchur, Volodymyr Melnykov, Volodymyr Marina, R. Yaremkevych, R. Zhuk, V. Bochar, Vitaliy Petrov, O. Samchuk, Dmytro Romanchak","doi":"10.25040/ntsh2023.01.06","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.06","url":null,"abstract":"The article raises a question about the possible and effective kidney transplantation in elderly patients with various severe comorbidities. The analysis is based on an example of successful kidney transplantation from a deceased donor when a 67-year-old patient had severe concomitant background: obesity, diabetes mellitus, and cardiovascular disturbances. Despite unfavorable prognosis and further unpredictable illnesses such as COVID-19, candidal esophagitis, coronary attack, and pneumonia, the patient has not develop graft injury or rejection and kept sufficient kidney function. \u0000The research was mainly focused on coexisting illnesses and their influence on kidney transplantation consequences. Following disease groups were discussed regarding their impact on transplantation outcomes and prognosis: arterial hypertension, cardiac disorders, diabetes mellitus, and obesity. Patient’s age, previous interventions, and comorbidities were observed for association with outcomes and risk of graft rejection. A review of available publications compared approaches for recipient selection in different clinical centers as well.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"107 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115157788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
On the occasion of the 25th anniversary of the death of Dr. Achilles N. Chreptowsky (June 6, 1920 – May 9, 1998), a long-time leader of the Ukrainian medical community, an active member of the Ukrainian Medical Association of North America, the initiator of the unification of Ukrainian medical communities around the world, the chairman of the World Federation of Ukrainian Medical Societies (SFULT) and the organizer of the first four congresses of WFUMA (World Federation of Ukrainian Medical Associations), including in Kyiv and Lviv in 1990 and also in Kharkiv in 1992; the restoration of the activities of the medical commission of the Shevchenko Scientific Society (NTSh) and its journal Likarsky visnih (currently the Proceedings of the Shevchenko Scientific Society. Medical Sciences (Medical Sciences, ISSN 2708-8634; eISSN 2708-8642), accounting for 2023, we present a conversation with his granddaughter Ms. Laryssa Ivanna Reifel (of the Chreptowsky family and current President of the Ukrainian Culture Center of Los Angeles) about the current problems of today's Ukraine during a full-scale war on its territory.
{"title":"FROM THE HEART OF ACHILLES CHREPTOWSKY: EX UNITATE VIRES (TRIBUTE FOR HIS 25TH ANNIVERSARY FROM DEATH)","authors":"Oksana Zayachkivska","doi":"10.25040/ntsh2023.01.18","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.18","url":null,"abstract":"On the occasion of the 25th anniversary of the death of Dr. Achilles N. Chreptowsky (June 6, 1920 – May 9, 1998), a long-time leader of the Ukrainian medical community, an active member of the Ukrainian Medical Association of North America, the initiator of the unification of Ukrainian medical communities around the world, the chairman of the World Federation of Ukrainian Medical Societies (SFULT) and the organizer of the first four congresses of WFUMA (World Federation of Ukrainian Medical Associations), including in Kyiv and Lviv in 1990 and also in Kharkiv in 1992; the restoration of the activities of the medical commission of the Shevchenko Scientific Society (NTSh) and its journal Likarsky visnih (currently the Proceedings of the Shevchenko Scientific Society. Medical Sciences (Medical Sciences, ISSN 2708-8634; eISSN 2708-8642), accounting for 2023, we present a conversation with his granddaughter Ms. Laryssa Ivanna Reifel (of the Chreptowsky family and current President of the Ukrainian Culture Center of Los Angeles) about the current problems of today's Ukraine during a full-scale war on its territory. ","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125302237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oleksiy Bashkirtsev, V. Gaevska, Z. Bilous, Liliia Lysa, O. Zimba
The novel coronavirus disease 2019 (COVID-19) has emerged as a global pandemic that has affected the lives of billions of people. Clinical studies have reported an association between COVID-19 and cardiac diseases. Remote monitoring powered by wearable sensors impacts medical care by enabling health monitoring outside of the clinic. Wearable devices can provide a noninvasive and continuous multi-parameter assessment of ECG, Heart Rate Variability, arterial blood pressure, oxygen saturation and respiratory rate evaluation. Such monitoring may help predict and prevent cardiovascular events related to COVID-19 addresses the growing demand for a novel 5P (Predictive, Preventive, Participatory, Personalized, and Precision) medicine approach. This article aimed to review current and prospective advances in wearable devices for cardiac monitoring and their progress toward clinical application during the COVID-19 pandemic. We performed bibliometric analysis by Scopus, the largest and well organized bibliographic database and analyzed the top-cited articles in this field. Our analysis includes an overview of the most widespread practical implications of CVD-focused remote patient monitoring techniques based on wearable personalized devices. Assessment for both COVID-related conditions and general cases is included in the analysis. Recent studies have reported that cardiac abnormalities present in 19.7-27.8 % of hospitalized patients with COVID-19. COVID-19 associated myocarditis and heart rate abnormalities frequently occur. Additionally, patients with pre-existing CVD and hypertension are at high risk of worse outcomes. Data from several studies have identified atrial fibrillation as the most common form of arrhythmias in COVID-19 patients. Worsening of existing atrial fibrillation in COVID-19 patients is also a serious clinical concern. Implementation of wearable ECG devices for remote monitoring can improve the management of patients with atrial fibrillation and those at high risk for its development. Telecardiology based on wearable devices and remote monitoring allow out-of-hospital control of COVID-19 patients and patients suffering from chronic diseases at high risk of acute cardiovascular events, ensuring their early detection and tracking.
{"title":"REMOTE MONITORING FOR 5P (PREDICTIVE, PREVENTIVE, PARTICIPATORY, PERSONALIZED, AND PRECISION) CARDIOVASCULAR MEDICINE: PROGRESS AMIDST COVID-19 PANDEMIC","authors":"Oleksiy Bashkirtsev, V. Gaevska, Z. Bilous, Liliia Lysa, O. Zimba","doi":"10.25040/ntsh2023.01.14","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.14","url":null,"abstract":"The novel coronavirus disease 2019 (COVID-19) has emerged as a global pandemic that has affected the lives of billions of people. Clinical studies have reported an association between COVID-19 and cardiac diseases. Remote monitoring powered by wearable sensors impacts medical care by enabling health monitoring outside of the clinic. Wearable devices can provide a noninvasive and continuous multi-parameter assessment of ECG, Heart Rate Variability, arterial blood pressure, oxygen saturation and respiratory rate evaluation. Such monitoring may help predict and prevent cardiovascular events related to COVID-19 addresses the growing demand for a novel 5P (Predictive, Preventive, Participatory, Personalized, and Precision) medicine approach. This article aimed to review current and prospective advances in wearable devices for cardiac monitoring and their progress toward clinical application during the COVID-19 pandemic. We performed bibliometric analysis by Scopus, the largest and well organized bibliographic database and analyzed the top-cited articles in this field. Our analysis includes an overview of the most widespread practical implications of CVD-focused remote patient monitoring techniques based on wearable personalized devices. Assessment for both COVID-related conditions and general cases is included in the analysis. Recent studies have reported that cardiac abnormalities present in 19.7-27.8 % of hospitalized patients with COVID-19. COVID-19 associated myocarditis and heart rate abnormalities frequently occur. Additionally, patients with pre-existing CVD and hypertension are at high risk of worse outcomes. Data from several studies have identified atrial fibrillation as the most common form of arrhythmias in COVID-19 patients. Worsening of existing atrial fibrillation in COVID-19 patients is also a serious clinical concern. Implementation of wearable ECG devices for remote monitoring can improve the management of patients with atrial fibrillation and those at high risk for its development. Telecardiology based on wearable devices and remote monitoring allow out-of-hospital control of COVID-19 patients and patients suffering from chronic diseases at high risk of acute cardiovascular events, ensuring their early detection and tracking.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125460263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Key points and main world trends are presented, including in the medical field, and personal experience and the trip’s mission are described.
介绍了要点和主要的世界趋势，包括在医疗领域，并描述了个人经历和此行的任务。
{"title":"WORLD ECONOMIC FORUM 2023. CURRENT TRENDS. UKRAINE. MEDICINE","authors":"Natalia Matolinets, Roman Smolynets","doi":"10.25040/ntsh2023.01.17","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.17","url":null,"abstract":"Key points and main world trends are presented, including in the medical field, and personal experience and the trip’s mission are described.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"114 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116682972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction. Patients with chronic heart failure are vulnerable to coronavirus disease (COVID-19). Objectives. To investigate risk factors for unfavorable prognosis and progression of heart failure in hospitalized patients with chronic heart failure and COVID-19 pneumonia. Methods. A retrospective analysis of the medical records of 555 hospitalized patients diagnosed with COVID-19 was conducted. Subsequently, the data of 90 patients with chronic heart failure (CHF) and COVID-19 pneumonia from January – February 2021 were collected at Lviv Clinical Hospital of Emergency Medical Care. The following indices were evaluated: anthropometric and demographic data, complications, treatment results, results of clinical, laboratory, and instrumental examinations, and dynamic NT-proBNP. Results. CHF is recorded in 42.9% of hospitalized patients with COVID-19 and is accompanied by lower values of blood oxygen level (p=0.0474), hemoglobin (p=0.0090), prothrombin time (p=0.0196), prothrombin index (p=0.0196) and higher indicators of glucose (p=0.0032), creatinine (p=0.00001), interleukin-6 (p=0.0041). CHF decompensation is associated with lower values of body temperature (p=0.0047) and blood oxygen saturation (p=0.0076), while hemoglobin level (p=0.0026), higher creatinine values (p=0.0034), interleukin-6 (p=0.0300), aspartate aminotransferase (p=0.0035), troponin I (p=0.0061); are associated with the development of myocardial infarction (p=0.0014), acute arrhythmias (p=0.0011), hypertensive crisis (p=0.0096) and increased mortality (OR=5.72; 95). % CI: 1.84, 17.81; p=0.0026). Conclusions. CHF is common and often fatal in patients with COVID-19, especially in decompensated CHF. Low blood oxygen saturation, myocardial infarction, arrhythmia, hypertensive crisis, increased cardio cytolysis markers and pro-inflammatory cytokines preceding adverse cardiovascular risk factors contribute to CHF decompensation in patients with COVID-19.
{"title":"RISK FACTORS FOR UNFAVORABLE PROGNOSIS AND PROGRESSION OF CHRONIC HEART FAILURE IN COVID-19 PNEUMONIA","authors":"O. Samchuk","doi":"10.25040/ntsh2023.01.12","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.12","url":null,"abstract":"Introduction. Patients with chronic heart failure are vulnerable to coronavirus disease (COVID-19). \u0000Objectives. To investigate risk factors for unfavorable prognosis and progression of heart failure in hospitalized patients with chronic heart failure and COVID-19 pneumonia. \u0000Methods. A retrospective analysis of the medical records of 555 hospitalized patients diagnosed with COVID-19 was conducted. Subsequently, the data of 90 patients with chronic heart failure (CHF) and COVID-19 pneumonia from January – February 2021 were collected at Lviv Clinical Hospital of Emergency Medical Care. The following indices were evaluated: anthropometric and demographic data, complications, treatment results, results of clinical, laboratory, and instrumental examinations, and dynamic NT-proBNP. \u0000Results. CHF is recorded in 42.9% of hospitalized patients with COVID-19 and is accompanied by lower values of blood oxygen level (p=0.0474), hemoglobin (p=0.0090), prothrombin time (p=0.0196), prothrombin index (p=0.0196) and higher indicators of glucose (p=0.0032), creatinine (p=0.00001), interleukin-6 (p=0.0041). CHF decompensation is associated with lower values of body temperature (p=0.0047) and blood oxygen saturation (p=0.0076), while hemoglobin level (p=0.0026), higher creatinine values (p=0.0034), interleukin-6 (p=0.0300), aspartate aminotransferase (p=0.0035), troponin I (p=0.0061); are associated with the development of myocardial infarction (p=0.0014), acute arrhythmias (p=0.0011), hypertensive crisis (p=0.0096) and increased mortality (OR=5.72; 95). % CI: 1.84, 17.81; p=0.0026). \u0000Conclusions. CHF is common and often fatal in patients with COVID-19, especially in decompensated CHF. Low blood oxygen saturation, myocardial infarction, arrhythmia, hypertensive crisis, increased cardio cytolysis markers and pro-inflammatory cytokines preceding adverse cardiovascular risk factors contribute to CHF decompensation in patients with COVID-19.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130350333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Petar Šušnjara, L. Perić, I. Drenjančević, Matea Vrbanić, Nikolina Kolobarić, Z. Mihaljević, Mihael Kolar, Suzana Matić, Marija Jelić Vuković
Objectives: Lutein is a carotenoid and one of the primary pigments with antioxidative effects found in the macula lutea of an eye. The present study aimed to determine the effects of lutein consumption in the form of functional food (hen eggs enriched with n-3 PUFAs, selenium, vitamin D and lutein) on macula lutea morphology by using an optical coherence tomography (OCT) in young healthy subjects. Participants and Methods: Randomized, double-blind, placebo-controlled pilot study included eleven healthy young subjects of both sexes (average age 18 to 28 years), assigned to a Nutri4 group and a control group. The Nutri4 group consumed nutritionally enriched hen eggs, while the control group consumed regular ones during the three-week protocol. At the beginning and end of the protocol, the subjects underwent ophthalmological examinations of the posterior eye segment by OCT. Venous blood was sampled to determine biochemical blood parameters (serum concentration of nutrients, liver enzymes, serum lipid profile, inflammatory markers). Results: Consumption of Nutri4 eggs led to a significant increase in n-3 PUFAs, lutein and vitamin E concentrations in serum. The average macular thickness (lower outer layer of the macula) was increased in the Nutri4 group, while no significant change was found in the retinal thickness of the control group after the dietary protocol. Urea was raised, and gamma-glutamyl aminotransferase significantly decreased in the Nutri4 group, while aspartate aminotransferase was increased in the control group after the corresponding dietary protocol. Conclusions: The consumption of enriched hen eggs has a beneficial effect on the thickness and volume of the retina.
{"title":"CAN AN EYE BENEFIT FROM AN EGG? ADDITION OF LUTEIN IN FUNCTIONAL FOOD PRODUCTS AFFECTS THE MACULA LUTEA OF YOUNG HEALTHY INDIVIDUALS","authors":"Petar Šušnjara, L. Perić, I. Drenjančević, Matea Vrbanić, Nikolina Kolobarić, Z. Mihaljević, Mihael Kolar, Suzana Matić, Marija Jelić Vuković","doi":"10.25040/ntsh2023.01.10","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.10","url":null,"abstract":"Objectives: Lutein is a carotenoid and one of the primary pigments with antioxidative effects found in the macula lutea of an eye. The present study aimed to determine the effects of lutein consumption in the form of functional food (hen eggs enriched with n-3 PUFAs, selenium, vitamin D and lutein) on macula lutea morphology by using an optical coherence tomography (OCT) in young healthy subjects. \u0000Participants and Methods: Randomized, double-blind, placebo-controlled pilot study included eleven healthy young subjects of both sexes (average age 18 to 28 years), assigned to a Nutri4 group and a control group. The Nutri4 group consumed nutritionally enriched hen eggs, while the control group consumed regular ones during the three-week protocol. At the beginning and end of the protocol, the subjects underwent ophthalmological examinations of the posterior eye segment by OCT. Venous blood was sampled to determine biochemical blood parameters (serum concentration of nutrients, liver enzymes, serum lipid profile, inflammatory markers). \u0000Results: Consumption of Nutri4 eggs led to a significant increase in n-3 PUFAs, lutein and vitamin E concentrations in serum. The average macular thickness (lower outer layer of the macula) was increased in the Nutri4 group, while no significant change was found in the retinal thickness of the control group after the dietary protocol. Urea was raised, and gamma-glutamyl aminotransferase significantly decreased in the Nutri4 group, while aspartate aminotransferase was increased in the control group after the corresponding dietary protocol. \u0000Conclusions: The consumption of enriched hen eggs has a beneficial effect on the thickness and volume of the retina.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127595810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oksana Zayachkivska, V. Lonchyna, Vasyl Kovalyshyn, D. Bidiuk, V. Vovk, N. Volodko, Oleh Danylyak, I. Dzis
2023 marks the 125th anniversary of the foundation of the Medical Commission of the Shevchenko Scientific Society’s publication, whose successor today is the journal Proceedings of the Shevchenko Scientific Society. Medical Sciences (Medical Sciences, ISSN 2708-8634; eISSN 2708–8642). Dr Eugen Ozarkevych, the founder and later the Chair of the Shevchenko Scientific Society’s Medical Commission in Lviv, initiated the publication of the scientific and practical journal “Medical Collection” («Лікарський збірник») in 1898. The journal’s primary purpose was to promulgate scientific achievements in the field of medicine in Ukrainian and to create Ukrainian medical terminology. This format allowed the reader to review scientific achievements in fundamental and clinical medicine, current medical problems, and new methods to in the prevention, diagnosis and treatment of various diseases. Ukrainian professional medical terminology was presented in this journal for the first time. Throughout its existence, this oldest medical journal, Medical Sciences, remains faithful to its historical multidisciplinary orientation. During the information and Russian war on the territory of Ukraine, Medical Sciences serves as a national heritage of Ukraine. It is recognized by international partners and indexed in scientometric bibliographic databases such as Scopus, Copernicus, Directory of Open Access Journals (DOAJ), and Google Scholar. As an Open Access Journal, it is read in 155 countries of the world.
{"title":"NEW CONCEPTUAL IDEAS IN THE PROCEEDINGS OF THE SHEVCHENKO SCIENTIFIC SOCIETY. MEDICAL SCIENCES (DEDICATED TO THE 125TH ANNIVERSARY SINCE ITS FOUNDATION)","authors":"Oksana Zayachkivska, V. Lonchyna, Vasyl Kovalyshyn, D. Bidiuk, V. Vovk, N. Volodko, Oleh Danylyak, I. Dzis","doi":"10.25040/ntsh2023.01.03","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.03","url":null,"abstract":"2023 marks the 125th anniversary of the foundation of the Medical Commission of the Shevchenko Scientific Society’s publication, whose successor today is the journal Proceedings of the Shevchenko Scientific Society. Medical Sciences (Medical Sciences, ISSN 2708-8634; eISSN 2708–8642). Dr Eugen Ozarkevych, the founder and later the Chair of the Shevchenko Scientific Society’s Medical Commission in Lviv, initiated the publication of the scientific and practical journal “Medical Collection” («Лікарський збірник») in 1898. The journal’s primary purpose was to promulgate scientific achievements in the field of medicine in Ukrainian and to create Ukrainian medical terminology. This format allowed the reader to review scientific achievements in fundamental and clinical medicine, current medical problems, and new methods to in the prevention, diagnosis and treatment of various diseases. Ukrainian professional medical terminology was presented in this journal for the first time. Throughout its existence, this oldest medical journal, Medical Sciences, remains faithful to its historical multidisciplinary orientation. During the information and Russian war on the territory of Ukraine, Medical Sciences serves as a national heritage of Ukraine. It is recognized by international partners and indexed in scientometric bibliographic databases such as Scopus, Copernicus, Directory of Open Access Journals (DOAJ), and Google Scholar. As an Open Access Journal, it is read in 155 countries of the world.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125278894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Nehrych, N. Matolinets, A. Netliukh, N. Prokopenko, S. Kyryliuk
SARS-CoV-2 and side effects of SARS-CoV-2 vaccination show tropism to nervous system structures. Neurological side effects from the central and peripheral nervous systems have been observed quite rarely after vaccination against COVID-19 compared to a large number of vaccinated individuals. The article presents a clinical case of simultaneous damage to the central and peripheral nervous systems in the form of acute autoimmune inflammatory encephalomyelopolyradiculoneuropathy, which occurred after receiving the first dose of the BNT162b2 mRNA vaccine. The severe course of encephalomyelopolyradiculoneuropathy with peripheral tetraplegia, sensory disturbances, bulbar syndrome, and dysautonomia, followed by the occurrence of pneumonia, secondary bacterial meningoencephalitis, the need for long-term mechanical ventilation led to the occurrence of pneumothorax and multiple organ failure, which caused the patient’s death after one and a half months of intensive therapy. Thus, the acute autoimmune inflammatory encephalomyelopolyradiculoneuropathy can be considered as a probable rare neurological complication of SARS-CoV-2 vaccination with mRNA-based vaccines. Encephalomyelopolyradiculoneuropathy can have a severe course, accompanied by multiple complications and leading to death. Establishing of the causal relationships of the occurrence of rare neurological pathological conditions close in time to vaccination against SARS-CoV-2 with mRNA-based vaccines requires additional further researches.
{"title":"ACUTE ENCEPHALOMYELOPOLYRADICULONEUROPATHY THAT OCCURRED AFTER BNT162B2 MRNA VACCINATION AGAINST COVID-19: A CLINICAL CASE REVIEW","authors":"T. Nehrych, N. Matolinets, A. Netliukh, N. Prokopenko, S. Kyryliuk","doi":"10.25040/ntsh2023.01.15","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.15","url":null,"abstract":"SARS-CoV-2 and side effects of SARS-CoV-2 vaccination show tropism to nervous system structures. Neurological side effects from the central and peripheral nervous systems have been observed quite rarely after vaccination against COVID-19 compared to a large number of vaccinated individuals. The article presents a clinical case of simultaneous damage to the central and peripheral nervous systems in the form of acute autoimmune inflammatory encephalomyelopolyradiculoneuropathy, which occurred after receiving the first dose of the BNT162b2 mRNA vaccine. The severe course of encephalomyelopolyradiculoneuropathy with peripheral tetraplegia, sensory disturbances, bulbar syndrome, and dysautonomia, followed by the occurrence of pneumonia, secondary bacterial meningoencephalitis, the need for long-term mechanical ventilation led to the occurrence of pneumothorax and multiple organ failure, which caused the patient’s death after one and a half months of intensive therapy. \u0000Thus, the acute autoimmune inflammatory encephalomyelopolyradiculoneuropathy can be considered as a probable rare neurological complication of SARS-CoV-2 vaccination with mRNA-based vaccines. Encephalomyelopolyradiculoneuropathy can have a severe course, accompanied by multiple complications and leading to death. Establishing of the causal relationships of the occurrence of rare neurological pathological conditions close in time to vaccination against SARS-CoV-2 with mRNA-based vaccines requires additional further researches.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121736569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The article presents the features of the morphologic structure of intracoronary thrombi and the prognosis of acute ST segment elevation myocardial infarction (STEMI) in patients of different age groups. Methods: Histological analysis of the aspirated intracoronary clots was performed in 97 patients with STEMI. The patients were divided into two groups: 11 patients aged under 44 (young group) and the remaining older than 45 (older group). The short-term prognosis was determined by: ST-segment resolution, achievement of good coronary flow, myocardial blush, indices of myocardial contractility, and QS wave formation on ECG. The study’s endpoints determined the long-term prognosis: The onset or worsening of angina symptoms, coronary revascularization (PCI or CABG), AMI, and death. Results: Elderly patients were substantially more likely to have a history of coronary artery disease, as well as angina attacks, or their equivalents, at rest a few days before the onset of STEMI and arterial hypertension. Dyslipidemia was significantly more common in young patients. Formation of microchannels within the thrombi was significantly more common among older patients. Achieving the target quality of microcirculation was substantially more frequent among young patients (p=0.007). The long-term prognosis was better in young patients due to the lower prevalence of the combined endpoint. Conclusions: Elderly patients were more likely to have intracoronary thrombi with microchannel formation, indicating a longer duration of the thrombotic process. The long-term prognosis after STEMI was significantly better in young patients.
{"title":"MORPHOLOGY OF INTRACORONARY THROMBI AND ITS PROGNOSIS IN YOUNG AND OLDER PATIENTS AFTER STEMI","authors":"D. Besh, O. Besh","doi":"10.25040/ntsh2023.01.13","DOIUrl":"https://doi.org/10.25040/ntsh2023.01.13","url":null,"abstract":"The article presents the features of the morphologic structure of intracoronary thrombi and the prognosis of acute ST segment elevation myocardial infarction (STEMI) in patients of different age groups. \u0000Methods: Histological analysis of the aspirated intracoronary clots was performed in 97 patients with STEMI. The patients were divided into two groups: 11 patients aged under 44 (young group) and the remaining older than 45 (older group). The short-term prognosis was determined by: ST-segment resolution, achievement of good coronary flow, myocardial blush, indices of myocardial contractility, and QS wave formation on ECG. The study’s endpoints determined the long-term prognosis: The onset or worsening of angina symptoms, coronary revascularization (PCI or CABG), AMI, and death. \u0000Results: Elderly patients were substantially more likely to have a history of coronary artery disease, as well as angina attacks, or their equivalents, at rest a few days before the onset of STEMI and arterial hypertension. Dyslipidemia was significantly more common in young patients. Formation of microchannels within the thrombi was significantly more common among older patients. Achieving the target quality of microcirculation was substantially more frequent among young patients (p=0.007). The long-term prognosis was better in young patients due to the lower prevalence of the combined endpoint. \u0000Conclusions: Elderly patients were more likely to have intracoronary thrombi with microchannel formation, indicating a longer duration of the thrombotic process. The long-term prognosis after STEMI was significantly better in young patients.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114990621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sleep is a state of the brain characterized by a low level of vigilance and diminished consciousness. The reaction to external stimuli and the processing of stimuli are attenuated in sleep. During sleep, the reticular thalamic nucleus inhibits at the thalamus the flow of sensory activity from the senses to the cerebral cortex. After arrival at the afferent layer of the primary cortex, the reduced sensory flow is analyzed and personalized by layers of the cortical area and transferred by the corticofugal system back to appropriate subdivisions of the thalamus. Thalamic subdivisions target the information of the senses to related areas of the cerebral cortex, where the messages can be (sub)consciously perceived. When necessary, the sleeper can be awakened by a wake-up call, either by stimuli indicating danger or by personally meaningful stimuli. Evidently, sensory gating in sleep has two main features. First, it is favorable for sleep, by reducing the cerebral brain activity through the reticular thalamic nucleus, and second, it is necessary for the sleepers' safety and well-being, by analyzing the preserved activity on essential or dangerous external elements by the corticofugal system. These two features are analyzed in detail in non-REM sleep as well as in REM sleep. In the latter type of sleep, the process of sensory gating is almost similar to non-REM sleep, despite the enigmatic reconstruction of external stimuli into the dream. With the extended corticofugal system, sleep phenomena as the first-night effect, the occurrence of local sleep and wake states, as well as the unihemispheric sleep are comprehensible.
{"title":"SENSORY GATING: BALANCE BETWEEN SLEEP AND LIFE","authors":"A. Coenen","doi":"10.25040/ntsh2022.02.07","DOIUrl":"https://doi.org/10.25040/ntsh2022.02.07","url":null,"abstract":"Sleep is a state of the brain characterized by a low level of vigilance and diminished consciousness. The reaction to external stimuli and the processing of stimuli are attenuated in sleep. During sleep, the reticular thalamic nucleus inhibits at the thalamus the flow of sensory activity from the senses to the cerebral cortex. After arrival at the afferent layer of the primary cortex, the reduced sensory flow is analyzed and personalized by layers of the cortical area and transferred by the corticofugal system back to appropriate subdivisions of the thalamus. Thalamic subdivisions target the information of the senses to related areas of the cerebral cortex, where the messages can be (sub)consciously perceived. When necessary, the sleeper can be awakened by a wake-up call, either by stimuli indicating danger or by personally meaningful stimuli. Evidently, sensory gating in sleep has two main features. First, it is favorable for sleep, by reducing the cerebral brain activity through the reticular thalamic nucleus, and second, it is necessary for the sleepers' safety and well-being, by analyzing the preserved activity on essential or dangerous external elements by the corticofugal system. These two features are analyzed in detail in non-REM sleep as well as in REM sleep. In the latter type of sleep, the process of sensory gating is almost similar to non-REM sleep, despite the enigmatic reconstruction of external stimuli into the dream. With the extended corticofugal system, sleep phenomena as the first-night effect, the occurrence of local sleep and wake states, as well as the unihemispheric sleep are comprehensible.","PeriodicalId":345961,"journal":{"name":"Proceeding of the Shevchenko Scientific Society. Medical Sciences","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123989636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：